Person: Brent Saunders

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Botox maker lowers outlook

Allergan forecasts 2019 revenue below expectations on looming competition for some of its top drugs and has shelved plans to sell its women’s health business.

business

Botox firm Allergan to spend €42m in Irish expansion

business

Michael Noonan: Pfizer's mega deal with Allergan is no threat Ireland's corporate tax rate

business

Actavis scoops rival for €62bn

business

Actavis to use Allergan name after $66bn takeover

business

Dublin pharma firm sued in NYC

Actavis to buy Forest Labs for $25bn

Dublin-based firm Actavis, one of the world’s largest generic-drugs makers by market value, has agreed to buy Forest Laboratories for about $25bn (€18bn).

Wed, 19 Feb, 2014

Health firm chief confident over corporation tax rate

THE US-based chief of one of the world’s leading eyecare product manufacturers has expressed confidence the Irish Government will “do the right thing” and maintain the current level of corporation tax.

Thu, 07 Apr, 2011